Saturn V Capital Management LP
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1964437
AUSTIN, TX
Position in AMLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$83,048,853
+$22,585,452 QoQ
Shares Held
4,624,101
+6.3% QoQ
Ownership
4.15%
of shares outstanding
% of Portfolio
11.91%
of 13F equity value
Holder Rank
#7
of 207 holders
Holding Since
Sep 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Saturn V Capital Management LP holds $83,048,853 across 1 Drug Manufacturers - Specialty & Generic name. AMLX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
4,624,101 | $83,048,853 |
All Filings in AMLX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $83,048,853 | 4,624,101 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $60,463,401 | 4,349,885 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $54,317,562 | 4,496,487 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $62,580,292 | 4,604,878 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $20,900,253 | 3,260,570 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,589,583 | 2,426,436 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,360,695 | 889,073 | Shares | Sole | 2025-02-14 | |
| 2023-12-31 | $16,181,224 | 1,099,268 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,225,278 | 886,143 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||